BioSpace News Archive

Deals

BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering

BriaCell Therapeutics Corp. today announced it has entered into securities purchase agreements with healthcare-focused institutional investors and a certain existing investor and a director of the Company for the purchase and sale of 2,402,935 common shares.

May 15, 2024
·
5 min read
Business

CervoMed Reports First Quarter 2024 Financial Results and Provides Corporate Updates

CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today reported its financial results for the first quarter ended March 31, 2024.

May 15, 2024
·
9 min read
Drug Development

Immutep Presents Data from Safety Lead-in Phase of AIPAC-003 at ESMO Breast 2024

Immutep Limited today announces encouraging efficacy, safety, and pharmacodynamic data from the safety lead-in of the AIPAC-003 Phase II/III trial presented at the European Society for Medical Oncology (ESMO) Breast Cancer 2024 Congress.

May 15, 2024
·
5 min read
Bio NC

Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy

Labcorp announced today the launch of its first trimester preeclampsia screening test to be performed between 11 and 14 weeks gestation to determine the risk of developing preeclampsia before 34 weeks of pregnancy.

May 15, 2024
·
4 min read
Drug Development

CASI Pharmaceuticals Receives FDA Clearance On The Investigational New Drug (IND) Application For CID-103 In Immune Thrombocytopenia (ITP)

CASI Pharmaceuticals, Inc. announced today the following: On April 12, 2024 CASI submitted the IND application to the FDA for CID-103 to support a phase 1/2 study of CID-103 in adults with chronic Immune Thrombocytopenia (ITP).

May 15, 2024
·
5 min read
RaeSedo Selected to Present New Approach to Asthma Treatment at the 2024 ATS Respiratory Innovation Summit

RaeSedo, Inc. today announced that it will present its pioneering approach to asthma treatment as a showcase company at the 2024 American Thoracic Society (ATS) Respiratory Innovation Summit (RIS).

May 15, 2024
·
6 min read
Gate Neurosciences to Share New Data and Research Insights on its Synaptic Function Molecules with Multiple Posters at 2024 ASCP Annual Meeting

Gate Neurosciences today announced upcoming activities at the 2024 annual meeting of the American Society of Clinical Psychopharmacology (ASCP), being held in Miami Beach, FL, from May 28-31, 2024.

May 15, 2024
·
4 min read
Business

TriSalus Reports Q1 2024 Financial Results and Business Update

TriSalus Life Sciences Inc., announced its financial results for the first quarter ended March 31, 2024, and provided a business update.

May 15, 2024
·
10 min read
Business

Aulos Bioscience Enters Into Clinical Trial Collaboration and Supply Agreement With Merck KGaA, Darmstadt, Germany To Study Combination of Bavencio® With AU-007

Aulos Bioscience today announced a new collaboration and supply agreement with Ares Trading S.A., a Swiss subsidiary of Merck KGaA, Darmstadt, Germany, for use of Bavencio® (avelumab) in a clinical study of its lead human monoclonal antibody candidate, AU-007.

May 15, 2024
·
4 min read
Biotech Beach

Aspen Neuroscience Receives CLIN2 Grant for ANPD001 from California Institute for Regenerative Medicine (CIRM)

Aspen Neuroscience, Inc. has received a CLIN2 grant award of $8 million from the California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, to support clinical research aimed at treating Parkinson’s disease (PD).

May 15, 2024
·
4 min read